Showing results (211-220 of 219) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 219 results.
BMJ Open|March 3, 2021
High-dose vitamin D supplementation to prevent prostate cancer progression in localised cases with low-to-intermediate risk of progression on active surveillance (ProsD): protocol of a phase II randomised controlled trialVisalini Nair-Shalliker, David P Smith, Val Gebski, et al.
Science Bulletin|January 21, 2026
Global, regional, and national burden of hepatocellular carcinoma and contribution of nine modifiable risk factors across 185 countries/territories in 2022Ping Li, Zhan Ding, Yuqi Feng, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|June 11, 2005
Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathwayRoberto Cappai, Su-Ling Leck, Deborah J Tew, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2008
Platinum-based inhibitors of amyloid-beta as therapeutic agents for Alzheimer's diseaseKevin J Barnham, Vijaya B Kenche, Giuseppe D Ciccotosto, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|September 28, 2007
In vitro characterization of Pittsburgh compound-B binding to Lewy bodiesMichelle T Fodero-Tavoletti, David P Smith, Catriona A McLean, et al.
The Journal of Biological Chemistry|April 6, 2006
Copper-mediated amyloid-beta toxicity is associated with an intermolecular histidine bridgeDavid P Smith, Danielle G Smith, Cyril C Curtain, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 25, 2005
Genome screen for loci influencing age at onset and rate of decline in late onset Alzheimer's diseasePeter Holmans, Marian Hamshere, Paul Hollingworth, et al.
British Journal of Cancer|December 21, 2025
High-dose vitamin D supplementation and prostate cancer progression: a phase II randomised trial in localised prostate cancer cases with intermediate risk of progression (ProsD)Visalini Nair-Shalliker, David P Smith, Val Gebski, et al.
Journal of Patient-Reported Outcomes|March 27, 2025
Development and psychometric evaluation of a patient-reported symptom index for patients with non-muscle invasive bladder cancer: the NMIBC-SIClaudia Rutherford, Margaret-Ann Tait, Daniel S J Costa, et al.
Pageof 22